Glycemic Effect of Colesevelam HCl (Welchol) in Patients With Type 2 Diabetes

Completed · Phase 2/Phase 3 · Has a placebo group

Conditions studied: Type 2 Diabetes

In brief

The purpose of this study is to obtain continuous glucose monitoring (CGM) data from individuals taking Welchol compared to placebo. The CGM data will determine the effect on glucose control of adding Welchol to an anti-diabetic medication regimen.

Key facts

Study ID
NCT00993824
Run by
HealthPartners Institute
People needed
21
Starts
2009-09-01
Expected to finish
2011-09-01
Last updated by the study team
2015-11-30

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.